Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma.
Kakadia S, Yarlagadda N, Awad R, Kundranda M, Niu J, Naraev B, Mina L, Dragovich T, Gimbel M, Mahmoud F. Kakadia S, et al. Among authors: yarlagadda n. Onco Targets Ther. 2018 Oct 17;11:7095-7107. doi: 10.2147/OTT.S182721. eCollection 2018. Onco Targets Ther. 2018. PMID: 30410366 Free PMC article. Review.
Immunotherapy Outcomes in Advanced Melanoma in Relation to Age.
Joshi K, Atwal D, Ravilla R, Pandey Y, Yarlagadda N, Kakadia S, Makhoul I, Hutchins L, Mahmoud F. Joshi K, et al. Among authors: yarlagadda n. Perm J. 2020;24:19.093. doi: 10.7812/TPP/19.093. Epub 2020 Feb 17. Perm J. 2020. PMID: 32097116 Free PMC article.
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma.
Mohan M, Gundarlapalli S, Szabo A, Yarlagadda N, Kakadia S, Konda M, Jillella A, Fnu A, Ogunsesan Y, Yarlagadda L, Thalambedu N, Munawar H, Graziutti M, Al Hadidi S, Alapat D, Thanendrarajan S, Zangari M, van Rhee F, Schinke C. Mohan M, et al. Among authors: yarlagadda n. Am J Hematol. 2022 Jun 1;97(6):E195-E198. doi: 10.1002/ajh.26530. Epub 2022 Mar 21. Am J Hematol. 2022. PMID: 35285981 Free article. No abstract available.
Hemophagocytic lymphohistiocytosis in adults.
Pandey Y, Atwal D, Konda M, Bimali M, Middleton D, Yarlagadda N, Firwana B, Sasapu A. Pandey Y, et al. Among authors: yarlagadda n. Proc (Bayl Univ Med Cent). 2020 Apr 3;33(3):326-330. doi: 10.1080/08998280.2020.1740052. eCollection 2020 Jul. Proc (Bayl Univ Med Cent). 2020. PMID: 32675947 Free PMC article.
Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns.
Schinke C, Boyle EM, Ashby C, Wang Y, Lyzogubov V, Wardell C, Qu P, Hoering A, Deshpande S, Ryan K, Thanendrarajan S, Mohan M, Yarlagadda N, Khan M, Choudhury SR, Zangari M, van Rhee F, Davies F, Barlogie B, Morgan G, Walker BA. Schinke C, et al. Among authors: yarlagadda n. Blood Cancer J. 2020 Jun 19;10(6):70. doi: 10.1038/s41408-020-0336-z. Blood Cancer J. 2020. PMID: 32555163 Free PMC article.
Nivolumab-induced immune-mediated neurotoxicity in Hodgkin lymphoma.
Lopez J, Yarlagadda N, Gheith Z, Mohan M, Sasapu A. Lopez J, et al. Among authors: yarlagadda n. Proc (Bayl Univ Med Cent). 2019 Oct 25;33(1):59-61. doi: 10.1080/08998280.2019.1668719. eCollection 2020 Jan. Proc (Bayl Univ Med Cent). 2019. PMID: 32063772 Free PMC article.
13 results